Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status

被引:49
作者
Johannesson, M
Landgren, BM
Csemiczky, G
Hjelte, L
Gottlieb, C
机构
[1] Huddinge Hosp, Dept Pediat, Stockholm CF Ctr, S-14186 Huddinge, Sweden
[2] Karolinska Hosp, Div Obstet & Gynecol, Dept Woman & Child Hlth, S-10401 Stockholm, Sweden
关键词
cystic fibrosis; female fertility; hormones; polycystic ovarian syndrome; reproduction;
D O I
10.1093/humrep/13.8.2092
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ten women with cystic fibrosis (CF) were evaluated with regard to hormonal profiles during a natural and a clomiphene citrate (CC) stimulated cycle. Five of the women were found to be anovulatory during a natural cycle. All women except one did respond with ovulation to CC stimulation indicating adequate ovarian response. Neither did they show increased follicle-stimulating hormone (FSH) concentrations on day 10 after CC treatment confirming normal ovarian reserve. Clinically the anovulatory women differed from the ovulating in two aspects: more profound essential fatty acid deficiency (EFAD) and higher peak/basal insulin response during an oral glucose tolerance test. The anovulatory women had significantly lower luteal oestradiol and progesterone but higher total testosterone concentrations when compared to healthy controls and the ovulatory CF women. The pathological insulin response and high testosterone concentrations resemble those seen in women with polycystic ovarian (PCO) syndrome. However, the CF patients in our study had normal ovaries, as deduced from ultrasound examination and normal luteinizing hormone (LH)/FSH ratio. It is suggested that EFAD as well as hypersecretion of insulin may be of importance for the observed ovarian dysfunction. Further studies are needed to evaluate the relation between ovulatory mechanisms and EFAD in CF women as well as studies to compare anovulatory CF women with women with PCO syndrome.
引用
收藏
页码:2092 / 2097
页数:6
相关论文
共 68 条
[1]   CONGENITAL BILATERAL ABSENCE OF THE VAS-DEFERENS - A PRIMARILY GENITAL FORM OF CYSTIC-FIBROSIS [J].
ANGUIANO, A ;
OATES, RD ;
AMOS, JA ;
DEAN, M ;
GERRARD, B ;
STEWART, C ;
MAHER, TA ;
WHITE, MB ;
MILUNSKY, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13) :1794-1797
[2]  
APKAN JO, 1981, ACTA DIABETOL LAT, V18, P147
[3]   ROLES OF INSULIN-RESISTANCE AND BETA-CELL DYSFUNCTION IN THE PATHOGENESIS OF GLUCOSE-INTOLERANCE IN CYSTIC-FIBROSIS [J].
AUSTIN, A ;
KALHAN, SC ;
ORENSTEIN, D ;
NIXON, P ;
ARSLANIAN, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :80-85
[4]  
BARASCH J, 1993, J CELL SCI, P229
[5]   Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome [J].
Barnes, RB .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1997, 15 (02) :159-168
[6]   NORMAL BRONCHIAL EPITHELIAL-CELLS CONSTITUTIVELY PRODUCE THE ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10, WHICH IS DOWN-REGULATED IN CYSTIC-FIBROSIS [J].
BONFIELD, TL ;
KONSTAN, MW ;
BURFEIND, P ;
PANUSKA, JR ;
HILLIARD, JB ;
BERGER, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (03) :257-261
[7]  
Burr GO, 1930, J BIOL CHEM, V86, P0587
[8]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[9]  
COHEN LF, 1980, LANCET, V2, P842
[10]   FREQUENCY OF 4 CYSTIC-FIBROSIS MUTATIONS IN A SWEDISH POPULATION [J].
DAHL, N ;
GRANDELL, U ;
MARTINSSON, T ;
ALLEN, M ;
JOHANSSON, L ;
STOLPE, L ;
GYLLENSTEN, U ;
HJELTE, L ;
KOLLBERG, H ;
STRANDVIK, B ;
WAHLSTROM, J ;
ANVRET, M .
ACTA PAEDIATRICA, 1993, 82 (6-7) :609-609